Literature DB >> 11238302

Double-gradient denaturing gradient gel electrophoresis assay for identification of L-ferritin iron-responsive element mutations responsible for hereditary hyperferritinemia-cataract syndrome: identification of the new mutation C14G.

L Cremonesi1, A Fumagalli, N Soriani, M Ferrari, S Levi, S Belloli, G Ruggeri, P Arosio.   

Abstract

BACKGROUND: Hereditary hyperferritinemia-cataract syndrome is an autosomic dominant disorder caused by heterogeneous mutations on the iron-responsive element (IRE) of ferritin L-chain mRNA. The mutations described to date were identified by direct sequencing of DNA from probands with hyperferritinemia often associated to bilateral cataracts. A direct genetic approach on a large population is useful to recognize polymorphisms in the DNA region and the prevalence of mutations associated with minor increases in serum ferritin and subclinical cataracts. We developed a rapid DNA scanning technique to detect mutations in a single electrophoretic analysis.
METHODS: The double-gradient denaturing gradient gel electrophoresis (DG-DGGE) method consisted of PCR amplification of the target genomic DNA with GC-clamped oligonucleotides. The sequence encoded the 5' untranslated flanking region of ferritin L-chain mRNA, which includes an IRE stem-loop structure. The product was subjected to DG-DGGE (8.5-15% polyacrylamide and 50-95% denaturant) to separate the homo- and heteroduplexes.
RESULTS: The method clearly identified all eight accessible mutations, including C-G transversions, which are the most difficult to detect. The method was applied to scan DNA samples from 50 healthy subjects and from 230 subjects with serum ferritin >400 microg/L. The new mutation G14C was identified.
CONCLUSIONS: The DG-DGGE method detects all the mutations in the L-ferritin IRE sequence, is rapid and economical, and can be applied to scan large populations. The first population study indicated that the mutations are rare and may involve regions of the IRE structure not yet characterized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238302

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

Review 1.  Recent advance in molecular iron metabolism: translational disorders of ferritin.

Authors:  Junji Kato; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Hereditary Hemochromatosis and Iron Metabolism.

Authors:  Joyce Carlson; Sigvard Olsson
Journal:  EJIFCC       Date:  2001-07-22

3.  Structural effects of linkage disequilibrium on the transcriptome.

Authors:  Joshua S Martin; Matthew Halvorsen; Lauren Davis-Neulander; Justin Ritz; Chetna Gopinath; Arthur Beauregard; Alain Laederach
Journal:  RNA       Date:  2011-11-22       Impact factor: 4.942

4.  Mutation analysis of the ferritin L-chain gene in age-related cataract.

Authors:  Nurit Assia; Nitza Goldenberg-Cohen; Gideon Rechavi; Ninette Amariglio; Yoram Cohen
Journal:  Mol Vis       Date:  2010-11-24       Impact factor: 2.367

5.  Disease-associated mutations that alter the RNA structural ensemble.

Authors:  Matthew Halvorsen; Joshua S Martin; Sam Broadaway; Alain Laederach
Journal:  PLoS Genet       Date:  2010-08-19       Impact factor: 5.917

Review 6.  Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder.

Authors:  Gunda Millonig; Martina U Muckenthaler; Sebastian Mueller
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

7.  Hyperferritinemia without iron overload in patients with bilateral cataracts: a case series.

Authors:  Arne Kröger; Esther B Bachli; Andrew Mumford; Christoph Gubler
Journal:  J Med Case Rep       Date:  2011-09-21

8.  Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing.

Authors:  R R Bennett; J den Dunnen; K F O'Brien; B T Darras; L M Kunkel
Journal:  BMC Genet       Date:  2001-10-17       Impact factor: 2.797

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.